Your browser doesn't support javascript.
loading
Maternal body mass index is associated with an altered immunological profile at 28 weeks of gestation.
Rees, April; Richards, Oliver; Allen-Kormylo, Anastasia; Jones, Nicholas; Thornton, Catherine A.
Afiliação
  • Rees A; Institute of Life Science, Swansea University Medical School, Swansea, UK.
  • Richards O; Institute of Life Science, Swansea University Medical School, Swansea, UK.
  • Allen-Kormylo A; Maternity and Child Health, Singleton Hospital, Swansea Bay University Health Board, Swansea, UK.
  • Jones N; Institute of Life Science, Swansea University Medical School, Swansea, UK.
  • Thornton CA; Institute of Life Science, Swansea University Medical School, Swansea, UK.
Clin Exp Immunol ; 208(1): 114-128, 2022 05 13.
Article em En | MEDLINE | ID: mdl-35304898
ABSTRACT
Healthy pregnancy is accompanied by various immunological and metabolic adaptations. Maternal obesity has been implicated in adverse pregnancy outcomes such as miscarriage, preeclampsia, and gestational diabetes mellitus (GDM), while posing a risk to the neonate. There is a lack of knowledge surrounding obesity and the maternal immune system. The objective of this study was to consider if immunological changes in pregnancy are influenced by maternal obesity. Peripheral blood was collected from fasted GDM-negative pregnant women at 26-28 weeks of gestation. Analysis was done using immunoassay, flow cytometry, bioenergetics analysis, and cell culture. The plasma profile was significantly altered with increasing BMI, specifically leptin (r = 0.7635), MCP-1 (r = 0.3024), and IL-6 (r = 0.4985). Circulating leukocyte populations were also affected with changes in the relative abundance of intermediate monocytes (r = -0.2394), CD4CD8 T-cell ratios (r = 0.2789), and NKT cells (r = -0.2842). Monocytes analysed in more detail revealed elevated CCR2 expression and decreased mitochondrial content with increased BMI. However, LPS-stimulated cytokine production and bioenergetic profile of PBMCs were not affected by maternal BMI. The Th profile skews towards Th17 with increasing BMI; Th2 (r = -0.3202) and Th9 (r = -0.3205) cells were diminished in maternal obesity, and CytoStim™-stimulation exacerbates IL-6 (r = 0.4166), IL-17A (r = 0.2753), IL-17F (r = 0.2973), and IL-22 (r = 0.2257) production with BMI, while decreasing IL-4 (r = -0.2806). Maternal obesity during pregnancy creates an inflammatory microenvironment. Successful pregnancy requires Th2-biased responses yet increasing maternal BMI favours a Th17 response that could be detrimental to pregnancy. Further research should investigate key populations of cells identified here to further understand the immunological challenges that beset pregnant women with obesity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Obesidade Materna Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Obesidade Materna Idioma: En Ano de publicação: 2022 Tipo de documento: Article